Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.
<h4>Background</h4>Mild cognitive impairment (MCI) refers to a transitional zone between normal ageing and dementia. Despite the uncertainty regarding the definition of MCI as a clinical entity, clinical trials have been conducted in the attempt to study the role of cholinesterase inhibi...
Guardado en:
Autores principales: | Roberto Raschetti, Emiliano Albanese, Nicola Vanacore, Marina Maggini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5877d46e95784f1c9c1d6c47a7760ce7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Screening for mild cognitive impairment in people with obesity: a systematic review
por: Nimantha Karunathilaka, et al.
Publicado: (2021) -
Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
por: Xiong Jiang, et al.
Publicado: (2021) -
Cognitive Intervention Using Information and Communication Technology for Older Adults with Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
por: Ae-Ri Jung, et al.
Publicado: (2021) -
Donepezil for mild cognitive impairment in Parkinson’s disease
por: Kyoungwon Baik, et al.
Publicado: (2021) -
Caregivers in China: knowledge of mild cognitive impairment.
por: Baozhen Dai, et al.
Publicado: (2013)